These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3499298)

  • 1. Urinary excretion of mefloquine and some of its metabolites in African volunteers at steady state.
    Schwartz DE; Eckert G; Ekue JM
    Chemotherapy; 1987; 33(5):305-8. PubMed ID: 3499298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose kinetic study of mefloquine in healthy male volunteers.
    Mimica I; Fry W; Eckert G; Schwartz DE
    Chemotherapy; 1983; 29(3):184-7. PubMed ID: 6603336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose kinetics of mefloquine in man. Plasma levels of the unchanged drug and of one of its metabolites.
    Schwartz DE; Eckert G; Hartmann D; Weber B; Richard-Lenoble D; Ekue JM; Gentilini M
    Chemotherapy; 1982; 28(1):70-84. PubMed ID: 6976886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divided-dose kinetics of mefloquine in man.
    Franssen G; Rouveix B; Lebras J; Bauchet J; Verdier F; Michon C; Bricaire F
    Br J Clin Pharmacol; 1989 Aug; 28(2):179-84. PubMed ID: 2789071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects.
    Schwartz DE; Weidekamm E; Mimica I; Heizmann P; Portmann R
    Chemotherapy; 1987; 33(1):1-8. PubMed ID: 3493885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human metabolism and excretion kinetics of aniline after a single oral dose.
    Modick H; Weiss T; Dierkes G; Koslitz S; Käfferlein HU; Brüning T; Koch HM
    Arch Toxicol; 2016 Jun; 90(6):1325-33. PubMed ID: 26233686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolism of Ro 21-5998 (mefloquine) in the rat (author's transl)].
    Jauch R; Griesser E; Oesterhelt G
    Arzneimittelforschung; 1980; 30(1):60-7. PubMed ID: 6966153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and excretion of ropivacaine in humans.
    Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
    Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
    Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
    Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excretion of mefloquine in human breast milk.
    Edstein MD; Veenendaal JR; Hyslop R
    Chemotherapy; 1988; 34(3):165-9. PubMed ID: 3262044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of ciclosporin and 17 of its metabolites in renal allograft recipients.
    Bleck JS; Schlitt HJ; Christians U; Thiesemann C; Strohmeyer S; Schottmann R; Kohlhaw K; Wonigeit K; Sewing KF
    Pharmacology; 1989; 39(3):160-4. PubMed ID: 2587622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of prophylactic mefloquine.
    Karbwang J; Molunto P; Na Bangchang K; Banmairuroi V; Bunnag D; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1991 Dec; 22(4):519-22. PubMed ID: 1820637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose kinetics of mefloquine in Brazilian male subjects.
    de Souza JM; Heizmann P; Schwartz DE
    Bull World Health Organ; 1987; 65(3):353-6. PubMed ID: 3499250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral contraceptive steroids on the clinical course of malaria infection and on the pharmacokinetics of mefloquine in Thai women.
    Karbwang J; Looareesuwan S; Back DJ; Migasana S; Bunnag D; Breckenridge AM
    Bull World Health Organ; 1988; 66(6):763-7. PubMed ID: 3266115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics and metabolism of 14C/13C-labeled ortho-phenylphenol formation following dermal application to human volunteers.
    Timchalk C; Selim S; Sangha G; Bartels MJ
    Hum Exp Toxicol; 1998 Aug; 17(8):411-7. PubMed ID: 9756132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective urinary excretion of bupivacaine and its metabolites during epidural infusion.
    Fawcett JP; Kennedy J; Kumar A; Ledger R; Zacharias M
    Chirality; 1999; 11(1):50-5. PubMed ID: 9914653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
    Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
    Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. Need for a better dosing regimen.
    Lobel HO; Bernard KW; Williams SL; Hightower AW; Patchen LC; Campbell CC
    JAMA; 1991 Jan; 265(3):361-4. PubMed ID: 1984534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of continuous venovenous haemodialysis on the pharmacokinetics of multiple oral moxifloxacin administration to patients with severe renal dysfunction.
    Stass H; Bührmann S; Mitchell A; Kubitza D; Möller JG; Kribben A; Wenzel RR; Schäfers RF
    Br J Clin Pharmacol; 2007 Dec; 64(6):745-9. PubMed ID: 17555469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of the diastereoisomer of mefloquine in mice.
    Chung H; Jimmerson VR; Rozman RS; Sanders JE
    Pharmacology; 1982; 24(5):267-74. PubMed ID: 6980423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.